XML 59 R46.htm IDEA: XBRL DOCUMENT v3.24.3

Segment Information (Tables)

9 Months Ended

Sep. 28, 2024

Segment Reporting [Abstract]

Schedule of Segment Information

The following tables present our segment information for the 13 and 39 weeks ended September 28, 2024 and September 30, 2023 (in $000’s):

			Thirteen Weeks Ended												Thirty-Nine Weeks Ended
			September 28, 2024						September 30, 2023						September 28, 2024						September 30, 2023
Revenues
Biotechnology			$	—					$	—					$	—					$	—
Fintech			4,941						—						7,110						—
Discontinued operations			—						—						—						3,795
Total Revenues			$	4,941					$	—					$	7,110					$	3,795
Gross profit
Biotechnology			$	—					$	—					$	—					$	—
Fintech			2,361						—						3,459						—
Discontinued operations			—						—						—						(197)
Total Gross profit			$	2,361					$	—					$	3,459					$	(197)
Operating income (loss)
Biotechnology			$	(1,574)					$	(764)					$	(6,557)					$	(2,923)
Fintech			353						—						614						—
Discontinued operations			—						—						—						14,158
Total Operating income (loss)			$	(1,221)					$	(764)					$	(5,943)					$	11,235
Depreciation and amortization
Biotechnology			$	438					$	363					$	1,604					$	1,090
Fintech			536						—						715						—
Discontinued operations			—						—						—						96
Total Depreciation and amortization			$	974					$	363					$	2,319					$	1,186
Interest (income) expense, net
Biotechnology			$	(363)					$	(758)					$	(272)					$	(1,598)
Fintech			110						—						267						—
Discontinued operations			—						—						—						181
Total Interest expense, net			$	(253)					$	(758)					$	(5)					$	(1,417)
Net income (loss) before income taxes
Biotechnology			$	(1,897)					$	(267)					$	(7,228)					$	(1,094)
Fintech			558						—						1,408						—
Discontinued operations			—						—						—						13,976
Total Net income before income taxes			$	(1,339)					$	(267)					$	(5,820)					$	12,882

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration